SAMANTHA MULL: Open Payments
NPI 1649044025 · PHILLIPSBURG, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 12 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $222 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $182 |
| Novo Nordisk Inc | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: ZEPBOUND, MOUNJARO, Rybelsus, CAPLYTA, INSPIRE, Cologuard Collection Kit, Ozempic, FARXIGA.
Industry payments across NJ — which companies pay providers there.
